Safeguard Investment Advisory Group’s AbbVie ABBV Stock Holding History

Safeguard Investment Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$448K	Buy	1,780 +79	+5%	+$17K	0.1%	94
2026 Q1	$370K	Sell	1,701 -219	-11%	-$48.6K	0.1%	82
2025 Q4	$439K	Sell	1,920 -15	-0.8%	-$3.42K	0.11%	81
2025 Q3	$448K	Sell	1,935 -84	-4%	-$17.1K	0.11%	85
2025 Q2	$375K	Sell	2,019 -663	-25%	-$123K	0.09%	93
2025 Q1	$564K	Buy	2,682 +881	+49%	+$171K	0.15%	62
2024 Q4	$320K	Sell	1,801 -49	-3%	-$9.01K	0.09%	80
2024 Q3	$365K	Buy	1,850 +543	+42%	+$101K	0.1%	73
2024 Q2	$224K	Buy	+1,307	New	+$217K	0.07%	93
2023 Q2	–	Sell	-1,506	Closed	-$240K	–	105
2023 Q1	$240K	Buy	+1,506	New	+$230K	0.12%	85
2021 Q1	–	Sell	-600	Closed	-$64K	–	80
2020 Q4	$64K	Buy	+600	New	+$57.7K	0.06%	169

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Safeguard Investment Advisory Group's ABBV Position: Q2 2026 in Review

Safeguard Investment Advisory Group increased its AbbVie (ABBV) stake by 4.6% in Q2 2026, buying an estimated $17K and bringing the position to 1,780 shares worth $448K. The position accounts for 0.1% of the portfolio, ranked #94.

Safeguard Investment Advisory Group first reported a position in ABBV in Q4 2020 and has held it in 11 quarters since. The position peaked at $564K in Q1 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Safeguard Investment Advisory Group held 1,780 shares of AbbVie worth $448K as of Q2 2026.
Safeguard Investment Advisory Group bought 79 AbbVie shares in Q2 2026, an estimated $17K.
AbbVie made up 0.1% of Safeguard Investment Advisory Group's portfolio in Q2 2026, its #94 holding.
Safeguard Investment Advisory Group first reported a position in AbbVie in Q4 2020 and has held it in 11 quarters since.
Safeguard Investment Advisory Group's AbbVie position peaked at $564K in Q1 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Safeguard Investment Advisory Group's 13F filing for Q2 2026, filed 13 Aug 2026.